Advino CuraLaser
World's first and only FDA approved device with two treatment modalities and two treatment heads in a single device
World's first and only FDA approved device with two treatment modalities and two treatment heads in a single device
Advino CuraLaser is a patented FDA approved device aiming to revolutionize musculoskeletal pain management. Founded in 2014, it offers a breakthrough solution to reduce pain through two treatment modalities and two therapeutic heads in a single device. In a market where surgeries and medications come with complications and side effects, CuraLaser stands out with its zero side effects and non-invasive approach. As a pioneer in the Health Care industry, it presents an attractive investment opportunity for Venture capital firms seeking disruptive innovations in the medical sector. With its unique value proposition, Advino CuraLaser is poised to make a significant impact in the field of pain management.
There is no investment information
No recent news or press coverage available for Advino CuraLaser.
We care about your data, and we'd love to use cookies make your experience better.